Issue Date: January 22, 2007
U.S. awards contracts for bird flu vaccine
The Department of Health & Human Services has awarded contracts totaling $132.5 million to three vaccine makers for the development of bird flu vaccines using an immune system booster, or adjuvant. HHS awarded five-year contracts to GlaxoSmithKline for $63.3 million and Novartis for $54.8 million. In addition, Iomai will receive $14.4 million, plus possible additional funding, to develop a vaccine patch. "In the event of an influenza pandemic, a vaccine that uses an adjuvant could provide a way to extend a limited vaccine supply," says HHS Secretary Michael O. Leavitt.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society